H02AB04 • methylprednisolone • Systemic hormonal preparations, excluding sex hormones and insulins | Corticosteroids for systemic use, plain | Glucocorticoids
Methylprednisolone is a corticosteroid used to treat a wide range of inflammatory and autoimmune conditions. It is indicated for diseases such as rheumatoid arthritis, systemic lupus erythematosus, severe asthma, inflammatory bowel diseases (such as Crohn's disease or ulcerative colitis), severe allergies, dermatitis, multiple sclerosis, and certain types of cancer. It is also used to prevent organ rejection after transplantation.
Methylprednisolone works by suppressing the body's inflammatory and immune response, reducing inflammation, swelling, redness, and pain. It is available in the form of tablets, injectable solutions, or creams, and the method of administration depends on the condition being treated.
The dosage and duration of treatment are determined by the doctor based on the severity of the disease and the patient's response. It is important not to stop treatment abruptly, especially after long-term use, as this can lead to adrenal insufficiency.
Common side effects include increased appetite, weight gain, insomnia, irritability, high blood pressure, fluid retention, and weakened immune function. Long-term use may lead to osteoporosis, diabetes, skin thinning, or Cushing's syndrome.
Patients should strictly follow their doctor's instructions and inform their healthcare provider about other medications they are taking, as methylprednisolone can interact with other treatments. It is also important to avoid exposure to infections, as the medication can weaken the immune response.
Substance: methylprednisolone
Date of last drug list: 01-07-2013
Commercial code: W04236001
Concentration: 125mg / 2ml
Pharmaceutical form: lyophilizate + solvent for injection
Quantity: 1
Product type: original
Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).